|
Market Cap (20-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 8 October 2021, 16:05. The announcement is marked as price sensitive, and is 2 page(s) in length and 198.87kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Depression Patent for Orotate Approved by US Patent Office | 8 October 2021, 16:05 |
| Nanocelle Issued Notice of Allowance by US Patent Office | 6 October 2021, 9:22 |
| Proposed issue of securities - MDC | 14 September 2021, 16:04 |
| Notice of Annual General Meeting/Proxy Form | 14 September 2021, 15:43 |
You must be logged in to post a reply.
Medlab Clinical 